Vaccines & Public Health: Our work
Our work
“We’re excited to be part of a new era of opportunity in line with the NHS long term plan”
– Ally Hughes, Commercial Access & Elimination Director
DEFEND YOUR TOMORROW 2025
Read about our public health campaign raising awareness of cervical cancer and how it may be preventable
VACCINE DELIVERY > MIDLANDS
Developing a new solution for the delivery of vaccination and immunisations
MSD is supporting to co-design a vaccine delivery solution in Nottingham and Nottinghamshire.
The above projects have been carried out under collaborative working agreements between MSD and the NHS. For further information on all collaborative working projects that MSD undertake, please visit Collaborative Working – MSD UK (msd-uk.com)
Achieving cervical cancer elimination in England: Sharing learnings, inspiring change
Our Race to Elimination best practice case study report
GB-NON-11851 | Date of Preparation: September 2025
Get in touch
Talk to one of the team about challenges you’re facing and find out how we can help
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Merck Sharp & Dohme (UK) Limited (Tel: 0208 154 8000).
Merck Sharp & Dohme (UK) Limited Registered Office: 120 Moorgate, London, EC2M 6UR, United Kingdom. Registered in England No. 233687 © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
GB-NON-11812 | Date of Preparation: September 2025
Hide Footer
